An old alliterative says that prior planning prevents poor performance. This is particularly true for cardiology practices considering the adoption of electronic medical record (EMR) technology, according to a speaker at the Towards the Electronic Patient Record (TEPR) conference in Baltimore [in May].
"You need a detailed knowledge of who you are, what you do, and how you do it," said Michael Mytych, principal of Health Information Consulting in Milwaukee, who presented his strategy for cardiac EMR implementation at the meeting.
Cardiac Cartography


Breakthrough Algorithms Predict Sudden Cardiac Death Risk

AHA in Chicago: GE Healthcare announced this week that it is the only company with two patented algorithms that meet new MN guidelines that help physicians predict whether a patient is at risk for sudden cardiac death (SCD).

A Netherlands study comparing two-year outcomes of a series of 708 consecutive diabetic patients (25 percent insulin treated) demonstrated that Taxus paclitaxel drug eluting stents were associated with a more favorable outcome in terms of major adverse cardiac events in a real world diabetic patient population as compared to the Cypher siralimus-eluting stents and bare metal stents. The study was presented Nov. 14 during the scientific sessions of the American Heart Association.

Diagnosoft, Inc. has received FDA approval for its HARP software that assists physicians in the analysis of magnetic resonance (MR) images by providing quantitative measurements and visualization of regional heart function.

Developed at and licensed from Johns Hopkins University, the technology is the first FDA approved software designed for the analysis of tagged MR images.

The Mobile Acuity LT Central Monitoring Station is designed to allow emergency caregivers to establish an Emergency Medical Delivery Area when and where it's needed. Central station monitoring is made to be deployed immediately on site in response to emergency situations to increase the level and timeliness of care for victims involved.

The FDA gave Humanitarian Device Exemption (HDE) approval for the AbioCor Implantable Replacement Heart (AbioCor). The approval will provide patients suffering from heart failure on both sides of their heart (bi-ventricular) and who have no other alternative a viable option for extending the quality of their life.
The AbioCor is the first completely self-contained artificial heart that may allow patients more time at home, without wires or tubes piercing through their skin. This technology provides patients with complete mobility and remote diagnostics.

In the CCU, ED or anywhere ECG records are needed, the Pyramis ECG Management System reportedly provides instant access to information, automating the process of managing information and eliminating time spent locating and retrieving records.

The company said the system integrates disparate patient data from legacy systems into a single, patient-centric, cardiology record with fast, accurate, reliable ECG processing, retrieval and distribution.

The Medtronic CareLink Network is the Internet-based remote monitoring service for patients with Medtronic implanted cardiac devices and their clinics.
Using a standard phone line, patients can send their device information to their clinics from the comfort of their home or while traveling.
The monitor plugs into a standard phone line, gathers the information and sends it to a secure storage site. The Internet is not needed to transmit.

The LATITUDE Patient Management System by Boston Scientific has FDA approval to be used in virtually all of the company's implantable defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). This approval increases the number of patients eligible to receive the benefits of home monitoring by more than 150,000 in the U.S.

The AfibAlert Atrial Fibrillation Monitor is a healthcare provider-prescribed ambulatory cardiac monitor for improved atrial fibrillation management. The pocket-sized monitor is a tool for the more than two million Americans who suffer from atrial fibrillation.

Subscribe Now